Lalan Wilfong, MD, Oncology, Dallas, TX, Texas Health Presbyterian Hospital Dallas

LalanScottWilfongMD

Oncology Dallas, TX

Physician

Dr. Wilfong is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wilfong's full profile

Already have an account?

Education & Training

  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolFellowship, Hematology/Oncology, 2000 - 2003
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolResidency, Internal Medicine, 1997 - 2000
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1997

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • National Board of Physicians and Surgeons Hematology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Lectures

  • Clinical and economic outcomes of pegfilgrastim in metastatic colorectal cancer. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • Innovation and Novel Therapies
    Innovation and Novel TherapiesMarch 2nd, 2020
  • Fifteen Practices in the US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 Million
    Fifteen Practices in the US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 MillionOctober 8th, 2019
  • NCCN: Costly Innovative Cancer Therapies Pose New Challenges—Financial and Otherwise
    NCCN: Costly Innovative Cancer Therapies Pose New Challenges—Financial and OtherwiseMarch 22nd, 2019
  • Join now to see all

Hospital Affiliations